Amin, R.; Muthuramu, I.; Aboumsallem, J.P.; Mishra, M.; Jacobs, F.; De Geest, B.
Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. Int. J. Mol. Sci. 2017, 18, 2012.
https://doi.org/10.3390/ijms18092012
AMA Style
Amin R, Muthuramu I, Aboumsallem JP, Mishra M, Jacobs F, De Geest B.
Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. International Journal of Molecular Sciences. 2017; 18(9):2012.
https://doi.org/10.3390/ijms18092012
Chicago/Turabian Style
Amin, Ruhul, Ilayaraja Muthuramu, Joseph Pierre Aboumsallem, Mudit Mishra, Frank Jacobs, and Bart De Geest.
2017. "Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload" International Journal of Molecular Sciences 18, no. 9: 2012.
https://doi.org/10.3390/ijms18092012
APA Style
Amin, R., Muthuramu, I., Aboumsallem, J. P., Mishra, M., Jacobs, F., & De Geest, B.
(2017). Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. International Journal of Molecular Sciences, 18(9), 2012.
https://doi.org/10.3390/ijms18092012
